OrganiGram Holdings Inc. (NASDAQ:OGI – Get Rating) – Research analysts at Atb Cap Markets issued their Q4 2023 EPS estimates for shares of OrganiGram in a report issued on Tuesday, November 29th. Atb Cap Markets analyst F. Gomes forecasts that the company will post earnings of ($0.01) per share for the quarter. The consensus estimate for OrganiGram's current full-year earnings is ($0.05) per share. Atb Cap Markets also issued estimates for OrganiGram's FY2024 earnings at $0.02 EPS.
Get OrganiGram alerts:OrganiGram Price Performance
Shares of NASDAQ:OGI opened at $1.10 on Thursday. The firm has a market capitalization of $345.20 million, a PE ratio of -27.50 and a beta of 0.75. The firm's 50-day moving average is $0.96 and its two-hundred day moving average is $1.03. OrganiGram has a 1 year low of $0.84 and a 1 year high of $2.13.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the business. Commonwealth Equity Services LLC boosted its stake in OrganiGram by 10.3% in the 1st quarter. Commonwealth Equity Services LLC now owns 100,801 shares of the company's stock worth $167,000 after buying an additional 9,382 shares during the last quarter. Swiss National Bank increased its holdings in shares of OrganiGram by 6.8% in the 1st quarter. Swiss National Bank now owns 604,000 shares of the company's stock valued at $1,004,000 after acquiring an additional 38,500 shares during the last quarter. Scotia Capital Inc. boosted its position in OrganiGram by 14.3% during the 1st quarter. Scotia Capital Inc. now owns 80,356 shares of the company's stock valued at $134,000 after purchasing an additional 10,073 shares during the period. Commerce Bank acquired a new position in OrganiGram during the 1st quarter valued at approximately $37,000. Finally, TD Asset Management Inc. boosted its position in OrganiGram by 4.6% during the 1st quarter. TD Asset Management Inc. now owns 258,051 shares of the company's stock valued at $430,000 after purchasing an additional 11,403 shares during the period. Hedge funds and other institutional investors own 11.87% of the company's stock.OrganiGram Company Profile
(Get Rating)
Organigram Holdings Inc, through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co, Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates.
Featured Stories
- Get a free copy of the StockNews.com research report on OrganiGram (OGI)
- Ford Revving Up Production Of EV Power Units At U.K. Plant
- Are the Short Sellers Still Right About Mullen Automotive stock?
- La-Z-Boy Reclines To More Comfortable Levels
- Is The Recovery Rally Here For SoFi?
- Is Apple Going To Rally Into Year End?
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.